Modeling Anaplastic Thyroid Carcinoma in the Mouse

Devora Champa, Antonio Di Cristofano

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Anaplastic thyroid carcinoma is the least common form of thyroid cancer; however, it accounts for the majority of deaths associated with this family of malignancies. A number of genetically engineered immunocompetent mouse models recapitulating the genetic and histological features of anaplastic thyroid cancer have been very recently generated and represent an invaluable tool to dissect the mechanisms involved in the progression from indolent, well-differentiated tumors to aggressive, undifferentiated carcinomas and to identify novel therapeutic targets. In this review, we focus on the relevant characteristics associated with these models and on what we have learned in terms of anaplastic thyroid cancer biology, genetics, and response to targeted therapy.

Original languageEnglish (US)
Pages (from-to)37-44
Number of pages8
JournalHormones and Cancer
Volume6
Issue number1
DOIs
StatePublished - 2014

Fingerprint

Genetic Models
Thyroid Neoplasms
Neoplasms
Carcinoma
Therapeutics
Anaplastic Thyroid Carcinoma

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Endocrine and Autonomic Systems

Cite this

Modeling Anaplastic Thyroid Carcinoma in the Mouse. / Champa, Devora; Di Cristofano, Antonio.

In: Hormones and Cancer, Vol. 6, No. 1, 2014, p. 37-44.

Research output: Contribution to journalArticle

@article{62cdf1556b864c04b0de4bf4f6f31598,
title = "Modeling Anaplastic Thyroid Carcinoma in the Mouse",
abstract = "Anaplastic thyroid carcinoma is the least common form of thyroid cancer; however, it accounts for the majority of deaths associated with this family of malignancies. A number of genetically engineered immunocompetent mouse models recapitulating the genetic and histological features of anaplastic thyroid cancer have been very recently generated and represent an invaluable tool to dissect the mechanisms involved in the progression from indolent, well-differentiated tumors to aggressive, undifferentiated carcinomas and to identify novel therapeutic targets. In this review, we focus on the relevant characteristics associated with these models and on what we have learned in terms of anaplastic thyroid cancer biology, genetics, and response to targeted therapy.",
author = "Devora Champa and {Di Cristofano}, Antonio",
year = "2014",
doi = "10.1007/s12672-014-0208-8",
language = "English (US)",
volume = "6",
pages = "37--44",
journal = "Hormones and Cancer",
issn = "1868-8497",
publisher = "Springer US",
number = "1",

}

TY - JOUR

T1 - Modeling Anaplastic Thyroid Carcinoma in the Mouse

AU - Champa, Devora

AU - Di Cristofano, Antonio

PY - 2014

Y1 - 2014

N2 - Anaplastic thyroid carcinoma is the least common form of thyroid cancer; however, it accounts for the majority of deaths associated with this family of malignancies. A number of genetically engineered immunocompetent mouse models recapitulating the genetic and histological features of anaplastic thyroid cancer have been very recently generated and represent an invaluable tool to dissect the mechanisms involved in the progression from indolent, well-differentiated tumors to aggressive, undifferentiated carcinomas and to identify novel therapeutic targets. In this review, we focus on the relevant characteristics associated with these models and on what we have learned in terms of anaplastic thyroid cancer biology, genetics, and response to targeted therapy.

AB - Anaplastic thyroid carcinoma is the least common form of thyroid cancer; however, it accounts for the majority of deaths associated with this family of malignancies. A number of genetically engineered immunocompetent mouse models recapitulating the genetic and histological features of anaplastic thyroid cancer have been very recently generated and represent an invaluable tool to dissect the mechanisms involved in the progression from indolent, well-differentiated tumors to aggressive, undifferentiated carcinomas and to identify novel therapeutic targets. In this review, we focus on the relevant characteristics associated with these models and on what we have learned in terms of anaplastic thyroid cancer biology, genetics, and response to targeted therapy.

UR - http://www.scopus.com/inward/record.url?scp=84925539009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925539009&partnerID=8YFLogxK

U2 - 10.1007/s12672-014-0208-8

DO - 10.1007/s12672-014-0208-8

M3 - Article

C2 - 25420535

AN - SCOPUS:84925539009

VL - 6

SP - 37

EP - 44

JO - Hormones and Cancer

JF - Hormones and Cancer

SN - 1868-8497

IS - 1

ER -